DOCSLIB.ORG

2019 AAVLD Proceedings

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2019 AAVLD Proceedings Cover art created with Fotosketcher IFC leave blank AAVLD Strategic Plan Updated August 7, 2019 Vision The AAVLD is a world leader in advancing the discipline of veterinary diagnostic laboratory science to promote global animal health and One Health. Mission The AAVLD promotes continuous improvement and public awareness of veterinary diagnostic laboratories by advancing the discipline of veterinary diagnostic laboratory science. The AAVLD provides avenues for education, communication, peer-reviewed publication, collaboration, outreach, and laboratory accreditation. Motto: Advancing veterinary diagnostic laboratory science Core values The AAVLD is committed to these core values: • Continuous improvement • Engagement of members • Effective communication • Collaboration • Support of One Health Goals 1. Advocate for the role of veterinary diagnostic laboratories in One Health by engaging in development of animal health initiatives, policies, and dissemination of surveillance information. 2. Foster continuous improvement of diagnostic laboratories through accreditation and continuing education activities while encouraging discovery and innovation in veterinary laboratory diagnostic sciences. 3. Strengthen communication with members and promote their continued professional growth. Our membership spans more than 32 countries worldwide. Join us today and discover for yourself the benefits and resources that AAVLD provides to its members. https://www.aavld.org https://www.facebook.com/AAVLD American Association of Veterinary Laboratory Diagnosticians The American Association of Veterinary Laboratory Diagnosticians (AAVLD) is a not-for-profit professional organization. AAVLD Officers, 2019 President Keith Bailey, Stillwater, OK President-elect Deepanker Tewari, Harrisburg, PA Vice-president Shuping Zhang, Columbia, MO Secretary-Treasurer Kristy Pabilonia, Fort Collins, CO Immediate Past-President Steve Hooser, West Lafayette, IN AAVLD Executive Director David H. Zeman, Brookings, SD Executive Director Assistant Reda Ozuna, Visalia, CA AAVLD Executive Board, 2019 President Keith Bailey, Stillwater, OK President-elect Deepanker Tewari, Harrisburg, PA Vice-president Shuping Zhang, Columbia, MO Secretary-Treasurer Kristy Pabilonia, Fort Collins, CO Immediate Past President Steve Hooser, West Lafayette, IN Northeast Robert Gibson, Durham, NH North Central Eric Burrough, Ames, IA Northwest Kevin Snekvik, Pullman, WA Southeast Jerry Saliki, Athens, GA South Central Amy Swinford, College Station, TX Southwest Ashley Hill, Davis, CA Canada Provincial Tomy Joseph, Abbotsford, BC Canada Federal, ex-Officio Maria Perrone, Ottawa, ON NVSL, ex-Officio Christina Loiacono, Ames, IA AVMA, ex-Officio Gail Golab, Schaumburg, IL AAVLD Business Office PO Box 6396, Visalia, CA 93290 Phone 559-781-8900 Fax 559-781-8989 Email: [email protected] Website: www.aavld.org Facebook: www.facebook.com/AAVLD/ Acknowledgments Each year’s meeting success depends on contributions from many individuals. I want to recognize all attendees, who make the annual meeting possible. A special thank you to all who present their studies and findings, and to all exhibitors and sponsors for supporting the annual meeting. We would also like to give special recognition to our invited speakers for the AAVLD Plenary Session and the USAHA-AAVLD Keynote speaker. Program Committee members deserve special thanks for reviewing and editing of the abstracts, and thanks are also due to moderators for hosting this year’s interesting and engaging scientific sessions. On behalf of entire AAVLD executive team, we are grateful for excellent administrative support provided by Reda Ozuna, flawless meeting coordination by Kaylin Taylor and program oversight offered by Dave Zeman in pulling together another successful annual meeting. Sincerely, Deepanker Tewari BVSc PhD DACVM ****************************************************************************** Program Committee Deepanker Tewari Chair Shuping Zhang Co-chair Tahseen Aziz Ashley Hill Keith Bailey Stephen Hooser Tim Baszler Tomy Joseph Steve Bolin Suresh Kuchipudi Jane Christopher-Hennings Christie Loiacono Kris Clothier Lisa Murphy Beate Crossley Kristy Pabilonia Pamela Ferro Nagaraja Thirumalapura Erin Goodrich Ines Walther Laura Goodman Scientific Session Moderators Kelli Almes Ailan Lim Catherine Barr Donna Mulrooney Grant Burcham Devi Patnayak Sarmila Dasgupta Akhilesh Ramachandran Pamela Ferro Karyn Bischoff Robert Gibson Orhan Sahin Laura Goodman Jonathan Samuelson Ashley Hill Durda Slavic Suresh Kuchipudi Maria Spinato J. Dustin Loy Rebecca Wilkes Hemant Naikare Yan Zhang ****************************************************************************** Please note: Abstracts published in these proceedings were peer reviewed by the members of the Program Committee for data supporting conclusions to be presented, and were edited into a consistent format. Full manuscripts were not evaluated and readers should contact the author for referral to a full presentation of data or for permission to use, copy, or distribute data contained in an abstract. 2019 Trainee Travel Awardees Molly Carpenter Colorado State University Juan Carlos Mora-Diaz Iowa State University Vanessa Oakes Virginia-Maryland CVM Sai Aravindh Sankara Narayanan Oklahoma State University Cristina Santana Maldonado Iowa State University Sreenidhi Srinivasan Penn State University Giovani Trevisan Iowa State University Yin Wang Kansas State University Jian Yuan Iowa State University Maodong Zhang University of Saskatchewan Grazieli Maboni University of Gerogia Cosponsored by the Bacteriology Committee Monika Samol University of California, Davis Cosponsored by the Epidemiology Committee Ava R. Jarvis Upstate Medical U. & Cornell U. Cosponsored by the Pathology Committee Viviana Gonzalez-Astudillo University of California, Davis Cosponsored by the Pathology Committee 2019 Staff Travel Awardees Renee Anderson Cornell University Brittany Chilson Cornell University Zachary Forbes Cornell University Suresh Kuchipudi Pennsylvania State University Nicole M. Andre Cornell University Cosponsored by the Pathology Committee 2019 Awards Committee Dr. Steve Hooser The AAVLD Foundation with funds received from our members and committees have provided over $30,000 Dr. Pat Halbur annually to support the advancement of our discipline and the development of the next generation of veterinary la- Dr. Tom Baldwin boratory diagnosticians. Thank you to all donors! Dr. Francois Elvinger The AAVLD Foundation Committee 2018 AAVLD Organizational Awardees E.P. Pope Award Dr. Craig Carter Distinguished Service Award Dr. Kristy Pabilonia Honorary Membership Award Brad Mollet Dr. Monique Eloit Life Membership Award Dr. Craig Carter 2018 AAVLD Committee Awards BIOMIC Award for Excellence in Diagnostic Microbiology Sponsored by Giles Scientific Dr. Erdal Erol Pioneers in Virology Award Dr. Julia Ridpath Richard L. Walker Best Classical Bacteriology Oral Presentation Award Sponsored by Anaerobe Systems April Aquino Estrada J. Lindsay Oaks Best Molecular Oral or Poster Presentation Award Sponsored by BioMerieux Linto Anthony Brenda Love Best Classical Bacteriology Poster Presentation Award Sponsored by VMRD Sreenidhi Srinivasan 2018 Joint AAVLD/ACVP Pathology Awards AAVLD/ACVP Diagnostic Pathology Resident/Graduate Student Award Yvonne Wikander ACVP/AAVLD Diagnostic Pathology Resident/Graduate Student Award Allison M. Watson blank page Table of Contents Room Page AAVLD Plenary Session Saturday, October 26, 2019 Advances in Diagnostics and Impact on One Health Exhibit Hall A 3 AAVLD Scientific Sessions Saturday/Sunday, October 26-27, 2019 Saturday Bacteriology 1 Room 554 7 Sunday Bacteriology 2 Ballroom E 17 Saturday Epidemiology 1 Room 555 29 Sunday Epidemiology 2 Ballroom C 39 Saturday Molecular Diagnostics and Bioinformatics 1 Ballroom E 51 Sunday Molecular Diagnostics and Bioinformatics 2 Room 555 61 Saturday Pathology 1 Room 557 77 Sunday Pathology 2 Room 556 87 Saturday Serology Ballroom C 101 Sunday Toxicology Room 557 111 Saturday Virology Room 556 125 Saturday & Sunday Poster Sessions Ballroom A 137 AAVLD Author Index 183 AAVLD Keyword Index 189 AAVLD Annual Conference Proceedings 1 Providence RI 2019 blank page Advances in Diagnostics and Impact on One Health Saturday, October 26th, 2019 7:45am- 11:30 am Exhibit Hall A Moderators: Deepanker Tewari and Shuping Zhang One Health: Challenges of Diagnostics for Zoonotic Infections Capt. Jennifer McQuiston, DVM, MS, Deputy Director Division of High Consequence Pathogens and Pathology/National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, GA One Health is a collaborative, multisectoral, and transdisciplinary approach to public health that aims to optimize health outcomes for people, animals, plants, and their shared environment. CDC uses a One Health approach to prevent zoonotic disease outbreaks by working with physicians, veterinarians, ecologists, and many others to monitor and control public health threats. Using current diagnostics and surveillance platforms for rabies, hantaviruses, and orthopoxviruses as key examples, this talk will discuss the unique public health challenges—and opportunities—posed by zoonotic infections. AAVLD Annual Conference Proceedings 3 Providence RI 2019 One Medicine, One Health: Dealing with Biological Risks and Mathematical Myths in Outbreaks of Highly Infectious Diseases Gavin Macgregor-Skinner, BVSc, MSc, MPH, MRCVS, Director of Strategic Partnerships in Disaster Medicine Department
Load more

Recommended publications
  • Biofilm Formation by Moraxella Catarrhalis
    BIOFILM FORMATION BY MORAXELLA CATARRHALIS APPROVED BY SUPERVISORY COMMITTEE Eric J. Hansen, Ph.D. ___________________________ Kevin S. McIver, Ph.D. ___________________________ Michael V. Norgard, Ph.D. ___________________________ Philip J. Thomas, Ph.D. ___________________________ Nicolai S.C. van Oers, Ph.D. ___________________________ BIOFILM FORMATION BY MORAXELLA CATARRHALIS by MELANIE MICHELLE PEARSON DISSERTATION Presented to the Faculty of the Graduate School of Biomedical Sciences The University of Texas Southwestern Medical Center at Dallas In Partial Fulfillment of the Requirements For the Degree of DOCTOR OF PHILOSOPHY The University of Texas Southwestern Medical Center at Dallas Dallas, Texas March, 2004 Copyright by Melanie Michelle Pearson 2004 All Rights Reserved Acknowledgements As with any grand endeavor, there was a large supporting cast who guided me through the completion of my Ph.D. First and foremost, I would like to thank my mentor, Dr. Eric Hansen, for granting me the independence to pursue my ideas while helping me shape my work into a coherent story. I have seen that the time involved in supervising a graduate student is tremendous, and I am grateful for his advice and support. The members of my graduate committee (Drs. Michael Norgard, Kevin McIver, Phil Thomas, and Nicolai van Oers) have likewise given me a considerable investment of time and intellect. Many of the faculty, postdocs, students and staff of the Microbiology department have added to my education and made my experience here positive. Many members of the Hansen laboratory contributed to my work. Dr. Eric Lafontaine gave me my first introduction to M. catarrhalis. I hope I have learned from his example of patience, good nature, and hard work.
    [Show full text]
  • Food Or Beverage Product, Or Probiotic Composition, Comprising Lactobacillus Johnsonii 456
    (19) TZZ¥¥¥ _T (11) EP 3 536 328 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 11.09.2019 Bulletin 2019/37 A61K 35/74 (2015.01) A61K 35/66 (2015.01) A61P 35/00 (2006.01) (21) Application number: 19165418.5 (22) Date of filing: 19.02.2014 (84) Designated Contracting States: • SCHIESTL, Robert, H. AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Encino, CA California 91436 (US) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • RELIENE, Ramune PL PT RO RS SE SI SK SM TR Los Angeles, CA California 90024 (US) • BORNEMAN, James (30) Priority: 22.02.2013 US 201361956186 P Riverside, CA California 92506 (US) 26.11.2013 US 201361909242 P • PRESLEY, Laura, L. Santa Maria, CA California 93458 (US) (62) Document number(s) of the earlier application(s) in • BRAUN, Jonathan accordance with Art. 76 EPC: Tarzana, CA California 91356 (US) 14753847.4 / 2 958 575 (74) Representative: Müller-Boré & Partner (71) Applicant: The Regents of the University of Patentanwälte PartG mbB California Friedenheimer Brücke 21 Oakland, CA 94607 (US) 80639 München (DE) (72) Inventors: Remarks: • YAMAMOTO, Mitsuko, L. This application was filed on 27-03-2019 as a Alameda, CA California 94502 (US) divisional application to the application mentioned under INID code 62. (54) FOOD OR BEVERAGE PRODUCT, OR PROBIOTIC COMPOSITION, COMPRISING LACTOBACILLUS JOHNSONII 456 (57) The present invention relates to food products, beverage products and probiotic compositions comprising Lacto- bacillus johnsonii 456. EP 3 536 328 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 536 328 A1 Description CROSS-REFERENCE TO RELATED APPLICATIONS 5 [0001] This application claims the benefit of U.S.
    [Show full text]
  • Blocking Transmission of Vector-Borne Diseases
    International Journal for Parasitology: Drugs and Drug Resistance 7 (2017) 90e109 Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijpddr Review Blocking transmission of vector-borne diseases * Sandra Schorderet-Weber a, Sandra Noack b, Paul M. Selzer b, Ronald Kaminsky c, a Sablons 30, 2000 Neuchatel,^ Switzerland b Boehringer Ingelheim Animal Health GmbH, Binger Str. 173, 55216 Ingelheim, Germany c ParaC Consulting for Parasitology and Drug Discovery, Altenstein 13, 79685 Haeg-Ehrsberg, Germany article info abstract Article history: Vector-borne diseases are responsible for significant health problems in humans, as well as in companion Received 14 November 2016 and farm animals. Killing the vectors with ectoparasitic drugs before they have the opportunity to pass Accepted 22 January 2017 on their pathogens could be the ideal way to prevent vector borne diseases. Blocking of transmission Available online 30 January 2017 might work when transmission is delayed during blood meal, as often happens in ticks. The recently described systemic isoxazolines have been shown to successfully prevent disease transmission under Keywords: conditions of delayed pathogen transfer. However, if the pathogen is transmitted immediately at bite as it Vector-borne diseases is the case with most insects, blocking transmission becomes only possible if ectoparasiticides prevent Transmission blocking Drug discovery the vector from landing on or, at least, from biting the host. Chemical entities exhibiting repellent activity Speed of kill in addition to fast killing, like pyrethroids, could prevent pathogen transmission even in cases of im- mediate transfer. Successful blocking depends on effective action in the context of the extremely diverse life-cycles of vectors and vector-borne pathogens of medical and veterinary importance which are summarized in this review.
    [Show full text]
  • Escherichia Coli Saccharomyces Cerevisiae Bacillus Subtilis はB
    研究開発等に係る遺伝子組換え生物等の第二種使用等に当たって執るべき拡散防止措 置等を定める省令の規定に基づき認定宿主ベクター系等を定める件 （平成十六年一月二十九日文部科学省告示第七号） 最終改正：令和三年二月十五日文部科学省告示第十三号 （認定宿主ベクター系） 第一条 研究開発等に係る遺伝子組換え生物等の第二種使用等に当たって執るべき拡散防止 措置等を定める省令（以下「省令」という。）第二条第十三号の文部科学大臣が定める認 定宿主ベクター系は、別表第一に掲げるとおりとする。 （実験分類の区分ごとの微生物等） 第二条 省令第三条の表第一号から第四号までの文部科学大臣が定める微生物等は、別表第 二の上欄に掲げる区分について、それぞれ同表の下欄に掲げるとおりとする。 （特定認定宿主ベクター系） 第三条 省令第五条第一号ロの文部科学大臣が定める特定認定宿主ベクター系は、別表第一 の２の項に掲げる認定宿主ベクター系とする。 （自立的な増殖力及び感染力を保持したウイルス及びウイロイド） 第四条 省令別表第一第一号ヘの文部科学大臣が定めるウイルス及びウイロイドは、別表第 三に掲げるとおりとする。 別表第１（第１条関係） 区 分 名 称 宿主及びベクターの組合せ １ Ｂ１ (１) ＥＫ１ Escherichia coli K12株、B株、C株及びW株又は これら各株の誘導体を宿主とし、プラスミド又は バクテリオファージの核酸であって、接合等によ り宿主以外の細菌に伝達されないものをベクター とするもの（次項(１)のＥＫ２に該当するものを除 く。） (２) ＳＣ１ Saccharomyces cerevisiae又はこれと交雑可能な 分類学上の種に属する酵母を宿主とし、これらの 宿主のプラスミド、ミニクロモソーム又はこれら の誘導体をベクターとするもの（次項(２)のＳＣ２ に該当するものを除く。） (３) ＢＳ１ Bacillus subtilis Marburg168株、この誘導体又 はB. licheniformis全株のうち、アミノ酸若しく は核酸塩基に対する複数の栄養要求性突然変異を 有する株又は胞子を形成しない株を宿主とし、こ れらの宿主のプラスミド（接合による伝達性のな いものに限る。）又はバクテリオファージの核酸 をベクターとするもの（次項(３)のＢＳ２に該当す るものを除く。） (４) Thermus属細菌 Thermus属細菌（T. thermophilus、T. aquaticus、 T. flavus、T. caldophilus及びT. ruberに限る。） を宿主とし、これらの宿主のプラスミド又はこの 誘導体をベクターとするもの (５) Rhizobium属細菌 Rhizobium属細菌（R. radiobacter（別名Agroba- cterium tumefaciens）及びR. rhizogenes（別名 Agrobacterium rhizogenes）に限る。）を宿主と し、これらの宿主のプラスミド又はRK2系のプラ スミドをベクターとするもの (６) Pseudomonas putida Pseudomonas putida KT2440株又はこの誘導体を 宿主とし、これら宿主への依存性が高く、宿主以 外の細胞に伝達されないものをベクターとするも の (７) Streptomyces属細菌 Streptomyces属細菌（S. avermitilis、S. coel- icolor [S. violaceoruberとして分類されるS. coelicolor A3(２)株を含む]、S. lividans、S. p- arvulus、S. griseus及びS.
    [Show full text]
  • Phase and Antigenic Variation Mediated by Genome Modifications
    Antonie van Leeuwenhoek (2008) 94:493–515 DOI 10.1007/s10482-008-9267-6 REVIEW PAPER Phase and antigenic variation mediated by genome modifications Florence Wisniewski-Dye´ Æ Ludovic Vial Received: 6 April 2008 / Accepted: 9 July 2008 / Published online: 29 July 2008 Ó Springer Science+Business Media B.V. 2008 Abstract Phase and antigenic variation is used by Keywords Adaptation Á Antigenic variation Á several bacterial species to generate intra-population Genome plasticity Á Phenotypic switch diversity that increases bacterial fitness and is important in niche adaptation, or to escape host defences. By this adaptive process, bacteria undergo frequent and usually reversible phenotypic changes Introduction resulting from genetic or epigenetic alterations at specific genetic loci. Phase variation or phenotypic One of the most obvious features of phase variation is switch allows the expression of a given phenotype to the appearance of a minority of colonies or colony be switched ON or OFF. Antigenic variation refers to sectors displaying a different aspect. Phase variation the expression of a number of alternative forms of an or phenotypic switch is used by several bacterial antigen on the cell surface, and at a molecular level, species to generate intra-population diversity that shares common features with phase variation mech- increases bacterial fitness and is important in niche anisms. This review will focus on phase and antigenic adaptation, or to escape host defences. Phase varia- variation mechanisms implying genome modifica- tion allows that the expression of a given phenotype tions, with an emphasis on the diversity of is either ON or OFF; these events are usually phenotypes regulated by these mechanisms, and the reversible (ON $ OFF) but may be irreversible ecological relevance of variant appearance within a (ON ? OFF or OFF ? ON), and result from genetic given population.
    [Show full text]
  • Genomics of Helicobacter Species 91
    Genomics of Helicobacter Species 91 6 Genomics of Helicobacter Species Zhongming Ge and David B. Schauer Summary Helicobacter pylori was the first bacterial species to have the genome of two independent strains completely sequenced. Infection with this pathogen, which may be the most frequent bacterial infec- tion of humanity, causes peptic ulcer disease and gastric cancer. Other Helicobacter species are emerging as causes of infection, inflammation, and cancer in the intestine, liver, and biliary tract, although the true prevalence of these enterohepatic Helicobacter species in humans is not yet known. The murine pathogen Helicobacter hepaticus was the first enterohepatic Helicobacter species to have its genome completely sequenced. Here, we consider functional genomics of the genus Helico- bacter, the comparative genomics of the genus Helicobacter, and the related genera Campylobacter and Wolinella. Key Words: Cytotoxin-associated gene; H-Proteobacteria; gastric cancer; genomic evolution; genomic island; hepatobiliary; peptic ulcer disease; type IV secretion system. 1. Introduction The genus Helicobacter belongs to the family Helicobacteriaceae, order Campylo- bacterales, and class H-Proteobacteria, which is also known as the H subdivision of the phylum Proteobacteria. The H-Proteobacteria comprise of a relatively small and recently recognized line of descent within this extremely large and phenotypically diverse phy- lum. Other genera that colonize and/or infect humans and animals include Campylobac- ter, Arcobacter, and Wolinella. These organisms are all microaerophilic, chemoorgano- trophic, nonsaccharolytic, spiral shaped or curved, and motile with a corkscrew-like motion by means of polar flagella. Increasingly, free living H-Proteobacteria are being recognized in a wide range of environmental niches, including seawater, marine sedi- ments, deep-sea hydrothermal vents, and even as symbionts of shrimp and tubeworms in these environments.
    [Show full text]
  • Table S5. the Information of the Bacteria Annotated in the Soil Community at Species Level
    Table S5. The information of the bacteria annotated in the soil community at species level No. Phylum Class Order Family Genus Species The number of contigs Abundance(%) 1 Firmicutes Bacilli Bacillales Bacillaceae Bacillus Bacillus cereus 1749 5.145782459 2 Bacteroidetes Cytophagia Cytophagales Hymenobacteraceae Hymenobacter Hymenobacter sedentarius 1538 4.52499338 3 Gemmatimonadetes Gemmatimonadetes Gemmatimonadales Gemmatimonadaceae Gemmatirosa Gemmatirosa kalamazoonesis 1020 3.000970902 4 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sphingomonas indica 797 2.344876284 5 Firmicutes Bacilli Lactobacillales Streptococcaceae Lactococcus Lactococcus piscium 542 1.594633558 6 Actinobacteria Thermoleophilia Solirubrobacterales Conexibacteraceae Conexibacter Conexibacter woesei 471 1.385742446 7 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sphingomonas taxi 430 1.265115184 8 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sphingomonas wittichii 388 1.141545794 9 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sphingomonas sp. FARSPH 298 0.876754244 10 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sorangium cellulosum 260 0.764953367 11 Proteobacteria Deltaproteobacteria Myxococcales Polyangiaceae Sorangium Sphingomonas sp. Cra20 260 0.764953367 12 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sphingomonas panacis 252 0.741416341
    [Show full text]
  • Enterohepatic Lesions in SCID Mice Infected with Helicobacter Bilis
    Laboratory Animal Science Vol 48, No 4 Copyright 1998 August 1998 by the American Association for Laboratory Animal Science Enterohepatic Lesions in SCID Mice Infected with Helicobacter bilis Craig L. Franklin, Lela K. Riley, Robert S. Livingston, Catherine S. Beckwith, Cynthia L. Besch-Williford, and Reuel R. Hook, Jr. Abstract _ Helicobacter bilis is a recently identified species that colonizes the intestine and liver of mice. In immunocompetent mice, infections have been associated with mild hepatitis, and in immunocompromised mice, inflammatory bowel disease has been induced by intraperitoneal inoculation of the organism. We re- port inoculation of 6-week-old C.B-17 scid/scid mice by gastric gavage with approximately 107 H. bilis colony- forming units. Groups of mice were euthanized and necropsied 12, 24, and 36 weeks after inoculation. Mild to moderate proliferative typhlitis was evident in all mice at 12 and 36 weeks after inoculation and in most mice 24 weeks after inoculation. Mild to severe chronic active hepatitis was detected in 10 of 10 male mice and 3 of 10 female mice. These results indicate that H. bilis can cause moderate to severe enterohepatic disease in immunocompromised mice. The genus Helicobacter is a rapidly expanding genus volved in lesion development. Culture of specimens from currently containing 17 named species. Members of this mice confirmed intestinal colonization with H. hepaticus. Fox genus are microaerophilic, have curved to spiral rod mor- et al. reported enteric lesions in immunocompetent germ- phology, and are motile by flagella that vary in number free Swiss Webster mice infected with H. hepaticus (15), and and location among various species (1).
    [Show full text]
  • Localization of Lactobacillus Plantarum in Bacterial Profile of Conjunctiva of Clinically Healthy Cattle
    Turkish Journal of Veterinary and Animal Sciences Turk J Vet Anim Sci (2013) 37: 302-305 http://journals.tubitak.gov.tr/veterinary/ © TÜBİTAK Research Article doi:10.3906/vet-1111-31 Localization of Lactobacillus plantarum in bacterial profile of conjunctiva of clinically healthy cattle Abdullah ARAGHI-SOOREH*, Meisam BANIARDALAN Department of Clinical Sciences, Faculty of Veterinary Medicine, Urmia Branch, Islamic Azad University, Urmia, Iran Received: 27.11.2011 Accepted: 14.08.2012 Published Online: 03.06.2013 Printed: 27.06.2013 Abstract: The aim of this study was to determine the normal conjunctival bacterial flora and the effects of sex and age variations on them in healthy cattle in Urmia, Iran. The animals (n = 50) were selected from 2 sexes and divided into 2 age groups. Swabs were taken from the inferior conjunctival sac of both eyes (n = 100) and were cultured on blood and MacConkey agar. All (100%) of the specimens yielded positive bacterial isolations. The bacterial isolates (in order of decreasing frequency) wereLactobacillus plantarum, Escherichia coli, Bacillus cereus, Proteus mirabilis, Enterobacter aerogenes, Staphylococcus epidermidis, and S. aureus. There was no significant difference in number of isolates between sexes and age groups (P > 0.05). In the present study L. plantarum, as a normal flora organism, was reported from the conjunctival sac in cattle for the first time. Key words: Lactobacillus plantarum, bacterial flora, conjunctiva, cattle 1. Introduction 2. Materials and methods Being rich in nutrients, several microorganisms are often Iranian Holstein crossbred cattle were examined from found on the eye’s surface, i.e. the ocular flora (1).
    [Show full text]
  • Genome-Wide Detection of Conservative Site- Specific Recombination in Bacteria
    RESEARCH ARTICLE Genome-wide detection of conservative site- specific recombination in bacteria Ognjen Sekulovic1*, Elizabeth Mathias Garrett2, Jacob Bourgeois1, Rita Tamayo2, Aimee Shen1, Andrew Camilli1* 1 Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America, 2 Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America * [email protected] (OS); [email protected] (AC) a1111111111 a1111111111 a1111111111 a1111111111 Abstract a1111111111 The ability of clonal bacterial populations to generate genomic and phenotypic heterogene- ity is thought to be of great importance for many commensal and pathogenic bacteria. One common mechanism contributing to diversity formation relies on the inversion of small geno- mic DNA segments in a process commonly referred to as conservative site-specific recom- OPEN ACCESS bination. This phenomenon is known to occur in several bacterial lineages, however it Citation: Sekulovic O, Mathias Garrett E, Bourgeois remains notoriously difficult to identify due to the lack of conserved features. Here, we report J, Tamayo R, Shen A, Camilli A (2018) Genome- an easy-to-implement method based on high-throughput paired-end sequencing for wide detection of conservative site-specific recombination in bacteria. PLoS Genet 14(4): genome-wide detection of conservative site-specific recombination on a single-nucleotide e1007332. https://doi.org/10.1371/journal. level. We demonstrate the effectiveness of the method by successfully detecting several pgen.1007332 novel inversion sites in an epidemic isolate of the enteric pathogen Clostridium difficile. Editor: Ivan Matic, Universite Paris Descartes, Using an experimental approach, we validate the inversion potential of all detected sites in INSERM U1001, FRANCE C.
    [Show full text]
  • Identification of a Novel Gene, Pilz, Essential for Type 4 Fimbrial
    JOURNAL OF BACTERIOLOGY, Jan. 1996, p. 46–53 Vol. 178, No. 1 0021-9193/96/$04.0010 Copyright q 1996, American Society for Microbiology Identification of a Novel Gene, pilZ, Essential for Type 4 Fimbrial Biogenesis in Pseudomonas aeruginosa RICHARD A. ALM, AMANDA J. BODERO, PATRICIA D. FREE, AND JOHN S. MATTICK* Centre for Molecular and Cellular Biology, University of Queensland, Brisbane, Queensland 4072, Australia Downloaded from Received 5 June 1995/Accepted 24 October 1995 The opportunistic pathogen Pseudomonas aeruginosa produces type 4 fimbriae which promote adhesion to epithelial cells and are associated with a form of surface translocation called twitching motility. We have used transposon mutagenesis to identify loci required for fimbrial assembly or function by screening for mutants that lack the spreading colony morphology characteristic of twitching motility. A subset of these mutants is resistant to fimbria-specific phage. One of these mutants (R270) was found to contain a transposon insertion in a new gene, termed pilZ, which is located on chromosomal SpeI fragment I at about 40 min on the P. http://jb.asm.org/ aeruginosa map, a position remote from other loci involved in fimbrial biogenesis. pilZ appears to be linked to and possibly forms an operon with a gene, holB*, which is homologous to the gene encoding the d* subunit of Escherichia coli DNA polymerase III. The product of the pilZ gene is a protein of 118 amino acids (predicted molecular weight, 12,895) which probably has a cytoplasmic location. PilZ appears to be a new class of protein which has not hitherto been represented in the sequence databases, and its function is unknown.
    [Show full text]
  • Iron As an Integral Constituent of Ancient Metabolism and Biochemistry
    IRON AS AN INTEGRAL CONSTITUENT OF ANCIENT METABOLISM AND BIOCHEMISTRY A Dissertation Presented to The Academic Faculty by Marcus Salvatore Bray In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in Biology Georgia Institute of Technology August 2019 COPYRIGHT © MARCUS SALVATORE BRAY 2019 IRON AS AN INTEGRAL CONSTITUENT OF ANCIENT METABOLISM AND BIOCHEMISTRY Approved by: Dr. Jennifer B. Glass, Advisor Dr. Loren Dean Williams, Co-Advisor School of Earth & Atmospheric Sciences School of Chemistry & Biochemistry Georgia Institute of Technology Georgia Institute of Technology Dr. Joel E. Kostka Dr. Kostas T. Konstantinidis School of Biological Sciences, School of School of Civil & Environmental Earth & Atmospheric Sciences Engineering Georgia Institute of Technology Georgia Institute of Technology Dr. Frank J. Stewart School of Biological Sciences Georgia Institute of Technology Date Approved: April 25th, 2019 “Into the desert, with only a head and some crossing wires to trace. Here's the world - the one that kills our fathers, and that births our children. May we forever wind, crawl and stumble below the stars, barely living before we shed our mind to teach ourselves anew.” -anonymous ACKNOWLEDGEMENTS I would first like to express my deep gratitude to both of my thesis advisors, Dr. Jennifer B. Glass and Dr. Loren Dean Williams for their continued guidance, support, and mentorship. I would also like to thank all the members of my thesis committee: Dr. Frank Stewart, Dr. Joel Kostka, and Dr. Kostas Konstantinidis for their service and support. I would like to thank members of both the Glass and Williams labs, with whom I had the pleasure of working closely during my time at Tech.
    [Show full text]